Screening for Prediabetes and Type 2 Diabetes

Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

(2019)   DIABETES CARE

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study

(2019) Qiuhong Gong et al.   Lancet Diabetes & Endocrinology

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial

(2019) Simon J Griffin et al.   Lancet Diabetes & Endocrinology

Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome

(2017) Katrine Hass Rubin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

(2017) Yan Zheng et al.   Nature Reviews Endocrinology

A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study

(2016) Rebecca K Simmons et al.   HEALTH TECHNOLOGY ASSESSMENT

Unknown

(2016)   DIABETIC MEDICINE

Unknown

(2016)   DIABETIC MEDICINE

Long-Term Effect of Population Screening for Diabetes on Cardiovascular Morbidity, Self-Rated Health, and Health Behavior

(2015) J. B. Echouffo-Tcheugui et al.   ANNALS OF FAMILY MEDICINE

Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement

(2015) Albert L. Siu et al.   ANNALS OF INTERNAL MEDICINE

Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)

(2015) William H. Herman et al.   DIABETES CARE

Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes

(2015) Maria Rosario G. Araneta et al.   DIABETES CARE

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015

(2015) Yehuda Handelsman et al.   Endocrine Practice

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels

(2015) Paola Portillo-Sanchez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reconsidering the Age Thresholds for Type II Diabetes Screening in the U.S.

(2014) Sukyung Chung et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study

(2014) Guangwei Li et al.   Lancet Diabetes & Endocrinology

Primary Prevention of Macroangiopathy in Patients With Short-Duration Type 2 Diabetes by Intensified Multifactorial Intervention: Seven-year follow-up of diabetes complications in Chinese

(2012) Y. Yang et al.   DIABETES CARE

How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort

(2012) M. Rahman et al.   DIABETOLOGIA

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

(2012) Rebecca K Simmons et al.   LANCET

Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care

(2012) K. Khunti et al.   BMJ-British Medical Journal

Trends in the Prevalence of Type 2 Diabetes in Asians Versus Whites: Results from the United States National Health Interview Survey, 1997-2008

(2011) J. W. R. Lee et al.   DIABETES CARE

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

(2011) Simon J Griffin et al.   LANCET

A1C to Detect Diabetes in Healthy Adults: When should we recheck?

(2010) O. Takahashi et al.   DIABETES CARE

Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort

(2010) R. K. Simmons et al.   DIABETOLOGIA

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

(2010) Richard Kahn et al.   LANCET

The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

(2009) Justin B Echouffo-Tcheugui et al.   BMC PUBLIC HEALTH

Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: A randomised controlled trial in British general practice

(2008) Paul Park et al.   BMC PUBLIC HEALTH

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial

(2008) M J Davies et al.   BMJ-British Medical Journal